AzTrials
AzTrials

Quality of LifeDQoL-OCNCT02463734

The Dementia Quality of Life Scale for Older Family Carers (DQoL-OC) Study

An observational study of Quality of Life, run by University of Nottingham at 14 sites in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this research is to develop the "DQoL-OC", a unique questionnaire to evaluate the quality of life of people aged 60 or above providing care for a family member with Alzheimer's disease or other related dementia at home in the UK. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Quality of Life
How many people
300 participants
Where
14 sitesUnited Kingdom
Study dates
Aug 2015to Feb 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Older family carers: To be an old person (between 60 and 100 years old), currently providing care for a family member with dementia (carers' self-report) at home in the UK, to understand and speak English, to accept to participate of the study

Who may be able to join

  • To be aged between 60 and 100 years old;
  • To be currently providing care for a family member with dementia (carers' -self-report) at home in the UK;
  • To speak and understand English;
  • To show an interest in participating in the research.

Who cannot join

  • To be aged under 60 years old or above 100 years old;
  • To provide paid care for the person with dementia;
  • Those with no familiar relationship with the person being cared for;
  • The family member with dementia is not being cared for at home;
  • The care is not provided in the UK;
  • The family member being cared for does not have dementia;
  • Do not speak or understand English.

Trial locations and contacts

14 sites in 1 country.

14 sites in 1 country

United Kingdom14 sites, 14 recruiting
  • Clinical Commissioning Group - Nottingham North & East GP practices

    Arnold, Nottinghamshire, NG5 6LU

    Paul Oliver, 0800 028 3693

    Recruiting
  • Community Mental Health Services for Older People - Mansfield and Ashfield Memory Assessment Service

    Ashfield, Nottinghamshire, NG174JL

    Ola Junaid, 01623 403 278

    Recruiting
  • Clinical Commissioning Group - Newark and Sherwood GP practices

    Balderton, Nottinghamshire, NG24 3HJ

    Mark Jefford, 01636 594824, Sarah.Hardy@newarkandsherwoodccg.nhs.uk

    Recruiting
  • Clinical Commissioning Group - Mansfield and Ashfield GP practices

    Mansfield, Nottinghamshire, NG21 OHJ

    Raian Sheikh, 0300 300 1234

    Recruiting
  • Community Mental Health Services for Older People - Newark and Sherwood Memory Assessment Service

    Newark, Nottinghamshire, NG24 4DE

    Ola Junaid, 01636 685 951

    Recruiting
  • Clinical Commissioning Group - Bassetlaw GP practices

    Nottingham, Nottinghamshire, DN22 7XF

    Stephen Kell, 01777 274400, BASCCG.FOIRequests@nhs.net

    Recruiting
  • Clinical Commissioning Group - Nottingham City GP practices

    Nottingham, Nottinghamshire, NG1 6GN

    Hugh Porter, 0115 845 4545

    Recruiting
  • Clinical Commissioning Group - Rushcliffe GP practices

    Nottingham, Nottinghamshire, NG11 6LQ

    Jeremy Griffiths, 0115 8837880, mail@rushcliffeccg.nhs.uk

    Recruiting
  • Community Mental Health Services for Older People - Rushcliffe Memory Assessment Service

    Nottingham, Nottinghamshire, NG2 6PR

    Ola Junaid, 0115 883 7417

    Recruiting
  • Community Mental Health Services for Older People - City Memory Assessment Service

    Nottingham, Nottinghamshire, NG5 1PB

    Ola Junaid, 0115 955 5419

    Recruiting
  • Community Mental Health Services for Older People - Gedling and Huckanall Memory Assessment Service

    Nottingham, Nottinghamshire, NG5 1PB

    Ola Junaid, 0115 969 1169 ext. 54702

    Recruiting
  • Community Mental Health Services for Older People - Brostowe Memory Assessment Service

    Nottingham, Nottinghamshire, NG9 8DB

    Ola Junaid, 0115 956 0813

    Recruiting
  • Clinical Commissioning Group - Nottingham West GP practices

    Stapleford, Nottinghamshire, NG9 8DB

    Guy Mansford, 0115 8835100, nottingham.west@nottinghamwestccg.nhs.uk

    Recruiting
  • Community Mental Health Services for Older People - Bassetlaw Memory Assessment Service

    Worksop, Nottinghamshire, S810BD

    Ola Junaid, 01909 502 408

    Recruiting

Other trials in United Kingdom

About this study

Official title: Development of the Dementia Quality of Life Scale for Older Family Carers of People With Dementia (DQoL-OC) and Evaluation of Its Psychometric Properties

The purpose of this research is to develop the "DQoL-OC", a unique questionnaire to evaluate the quality of life of people aged 60 or above providing care for a family member with Alzheimer's disease or other related dementia at home in the UK.

This questionnaire is aimed at allowing researchers, health and social professionals, as well as the older family carers themselves, to quantify the impact caring in different aspects life, for the purposes of economic evaluation or implementation and evaluation of interventions. The results from this study will also help us to understand better the aspects that affect carers' quality of life and well-being, which may guide future policies and the support provided to older family carers in the future.

Read more

The DQoL-OC is being developed in two parts. The first part is now completed and was carried out through focus groups with older family carers for discussions about important aspects related to their quality of life and well-being in order to create the items of the new questionnaire. Its preliminary version contains 100 questions about the practical aspects of care and caregiving, carers' feelings and concerns and satisfaction with life and with the caring role.

The second part of the DQoL-OC development is currently being carried out and aims to evaluate its validity and reliability for use with older family carers and to reduce it into a smaller number of items. About 300 older family carers are invited to answer individually the DQoL-OC and other similar questionnaires for these purposes. About 25 participants taking part in this study are invited to answer the same questions with an interval of two weeks in order to allow us to compare the results and its stability over this period of time.

Read the detailed description

STUDY AIM: This study aims to develop a unique questionnaire to evaluate the quality of life of older people providing care to family members with dementia at home and living in the UK and evaluate its psychometric properties. It is aimed to allow researchers, health and social professionals, as well as support groups' leaders, to quantify the experience of care in old age, for the implementation and evaluation of interventions with these older family carers aiming to improve their QoL. STUDY DESIGN: This study is being carried out through a quantitatively focused sequential and exploratory mixed methods' design (qual ->QUAN) (Creswell and Clark, 2011). It is a multi-centre and convenient sampled study (no randomization). Focus groups were carried out in Nottinghamshire to ask the older family carers what is important for their QoL (REC reference: D10072014 SoHS). The next study phase will be carried out through pilot and re-test studies by using the newly developed DQoL-OC and other validated scales. The study is managed from within the School of Health Sciences at the University of Nottingham.

SELECTION AND WITHDRAWAL OF PARTICIPANTS: The study participants (n=300) will be recruited from GP centres and Memory assessment services. Research posts and leaflets will be available in visible places in the aforementioned NHS settings where family carers usually have access. NHS staff may contact those family carers registered in the NHS system by e-mail in order to inform them about the study. Potential participants will voluntarily contact the PhD researcher Deborah Oliveira by e-mail, work address or telephone number for more information. The research material (questionnaires and PIS) will be posted in a pre-paid envelope to participants' address. About 25 participants taking part in the pilot study will be invited to answer the same questionnaires for a second time, in a re-test session, two weeks after the first set of measures. Participants that accept to take part on the re-test will be sent a second envelope containing the same research material to be filled in and posted back to the researcher within 14 days. This second questionnaire will be sent together with the first one, so no address storage will be necessary. Each participant will be taking part in the study for up to 45 minutes on average. If the participant wants to participate in the re-test phase (2 weeks interval), this amount of time should be doubled. This research will not collect participants' Informed consent (IC), as only questionnaires will be utilized. Completion and subsequent return of questionnaires will be taken as IC and separate written IC will not be sought. Participants taking part in the re-test will receive both sets of measures (two weeks interval) at once and their address information will be immediately destroyed. Participants will be informed that if in 30 days after the pilot questionnaire is received the re-test measures are not received, this will be considered a withdraw from the re-test study and only the pilot measures will be considered for the study.

Pilot study: Research data is collected using a research booklet containing the preliminary version of the DQoL-OC and participants are also invited to comment on the clarity, difficulty and relevance of the overall scale by using Likert scales (1-5), with possible answers ranging from 'very clear' to 'not clear at all' for clarity, 'very difficult' to 'very easy' for levels of difficulty and 'strongly relevant' to 'strongly irrelevant' for relevance, with space for comments in each of these questions. Participants are also invited to comment about the presence of any possible upsetting question. In the same booklet, other self-response questionnaires related to QoL and health are included in order to measure the convergent construct validity of the new scale: the Satisfaction with Life Scale (SWLS) (Diener et al., 1985); the Perceived Health Status Visual Analogue Scale (VAS) (Weinman et al., 1995); an overall HRQoL VAS (Torrance, 1978, Carlsson, 1983, EuroQol, 1990, Bleichrodt and Johannesson, 1997, Lundberg et al., 1999, Shmueli, 1999, Boer et al., 2004, Shmueli, 2005); the World Health Organization Quality of Life Scale for Aging Population - The WHOQOL-AGE (Caballero et al., 2013). The first version of the DQoL-OC had its items created based on the aforementioned qualitative findings and was submitted to an experts' panel to evaluate its relevance and clarity (face and content validity). The preliminary version of the DQoL-OC is divided in three separate sessions totalling 100 questions related to 1) practical aspects of care and caregiving, 2) carers' feelings and concerns and 3) satisfaction with life and caring. All the questions are designed in Likert format (1-5), ranging from "never" to "always", "not at all" to "as much as needed" and "very satisfied" to "very dissatisfied". At the end of the questionnaire there are two open questions that allow carers to write down what most affect their QoL and if there is anything else that was not covered in the questionnaire but yet is important for their QoL.

Re-test: A smaller group of participants (n maximum=25) taking part in the pilot study will be invited by the Researcher to answer the same questionnaires for a second time, in a re-test session, two weeks after the first set of measures. The same procedures utilized in the pilot study will be applied here with regards participant recruitment. Participants that accept to take part on the re-test will be sent a second envelope containing the same research material to be filled in and posted back to the researcher within 14 days. This second envelope will be posted together with the pilot questionnaire and will receive the same code added of a letter for identification and future comparisons. Participants will be informed that they can withdraw of this research activity if they wish to before the 14 days deadline and it is the researcher's responsibility to identify another participant to be included in the re-test study if that is the case. Besides their address details, no other personal data is collected.

DATA ANALYSIS: All the statistic tests will be developed in SPSS 22 statistics package, with confidence intervals of 95% and significant p-value ≤ 0.05. Descriptive (frequencies, mean, median, mode, and standard deviation), suitable correlation statistics (ANOVA) and ceiling and floor effect will be calculated for all the variables. The participants' subjective views regarding the clarity, relevance, levels of difficulty of the new scale DQoL-OC will be analysed by using Kappa coefficient, in order to provide an average score of agreement among the participants about the overall instrument (Streiner and Norman, 1995, Rubio et al., 2003, Leung et al., 2005, Polit and Beck, 2006, Nagpal et al., 2010, Wassef et al., 2014, Landis and Koch, 1977). Aiming to determine whether the DQoL-OC assess the same construct of QoL as other valid and reliable instruments selected from the literature, the construct validity of the DQoL-OC will be evaluated through suitable correlation statistics (ANOVA), correlating the DQoL-OC scores and the other validated scales completed by the participants, as previously mentioned. In addition to that, Factor analysis (FA) will be used to explore the inter relationship between the variables and to further refine and reduce the instrument. For FA, besides the sample size, the strengths of the inter-correlations between the items also must be considered. First of all it is necessary to inspect the correlation matrix to evaluate the suitability of data to FA (should be ≥ 0.30) (Tabachnick and Fidell, 1996). In addition, the extent of Kaiser-Meyer-Oklin of sample adequacy will be performed (which should be ≥ 0.60) (Kaiser and Caffey, 1965, Kaiser, 1970, Dziuban and Shirkey, 1974) and the significance of the Bartlett's Test of Sphericity correlation (Bartlett, 1954) will be analysed to support the factorability of the correlation matrix. According to these results, the data will be submitted to the FA or will be further modified to suitable it to FA. To give an estimate of the equivalence of sets of items from the same instrument, based on the assumption that items measuring the same construct should correlate, the internal consistency of the DQoL-OC will be calculated by using Cronbach's coefficient. Finally, aiming to evaluate whether the measurements provided by the DQoL-OC are stable over the time, the two set of measures of the participants who take part in the re-test will be compared by using Kappa coefficient, with scores ≥ 0.60 for good re-test reliability. The closer the results, the greater the test-retest reliability of the DQoL-OC. The data analysis will take place in UoN computers and will be backed up to the UoN servers.

SAMPLE SIZE AND JUSTIFICATION: There are no agreement in the literature regarding the appropriate sample size to use when conducting a factor analysis (Mundfrom et al., 2005). Even though bigger sample sizes (n>500) are indicative of better factor discrimination (Costello and Osborne, 2005) there are several studies showing that adequate sample size is partly determined by the nature of the data and not only the number of participants, meaning that the stronger the data, the smaller the sample is necessary for an accurate analysis (Fabrigar et al., 1999, MacCallum et al., 1999). Strong data for factor analysis is associated with uniformly high communalities without cross loadings and several variables loading strongly on each other, with such characteristics being considered rare (Costello and Osborne, 2005). Although absolute minimum sample size is not often presented in the literature, in general, small sample sizes are accepted for higher levels of communality within the data and higher ratios of the number of variables to the number of factors (Mundfrom et al., 2005). Mundfrom et al. (2005) stress that small number of variables requires a larger minimum sample size than does a large number of variables, as the relation between the minimum necessary sample size and the number of variables seems compensator, as it does the relation between the minimum necessary sample size and the ratio of the number of variables to the number of factors. These authors propose that for a low communality factors within the matrix under study, a minimum acceptable sample size would be 200 participants. Accordingly, it was stipulated a maximum of 300 participants in this pilot study, considering that the factor communality under study is still unknown and also being careful with the possibility of missing data. The n=25 for the reliability re-test also followed the recommendations available in the literature (Sim and Wright, 2005). Besides the sample size, the strengths of the inter-correlations between the items will be evaluated with the Bartlett test of Sphericity and the extent of Kaiser-Meyer-Oklin (KMO) of sampling adequacy will also be used to assess the adequacy of the data for FA. The data will be then submitted to the FA or will be further modified for suitability for FA. If the study needs a bigger sample size, the Ethics Committee will be contacted and an approval to exceed the number of participants will be sought before the recruitment of more carers.

DATA DISSEMINATION: The findings of the study will be written as part of a PhD thesis in the University of Nottingham with submission date expected for September 2016. The results may be submitted for publication in peer reviewed journals or to academic or scientific events. The data provided by the participants are anonymous and the answers of each participant will receive as specific code that only the Chief investigator and co-investigators will have access. The data may also be used to inform future research and policy. The participants and other stakeholders may receive a fed back of the results in anonymity.

Conditions
Quality of Life

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Health related quality of life (HRQoL)

    Questionnaire

    Measured: 8 months

Secondary outcomes (3)
  1. Health status

    Questionnaire

    Measured: 8 months

  2. Caring issues

    Questionnaire

    Measured: 8 months

  3. Socio-demographic data

    Questionnaire

    Measured: 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2015 (estimated)
  2. Study startAug 2015
  3. Primary completionFeb 2016 (estimated)
  4. Study completionFeb 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Cross-sectional
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02463734
Sponsor's protocol ID
15045
Other IDs
302813-5
Acronym
DQoL-OC
Status last verified
Dec 2015
First submitted
2 Jun 2015
Last updated
3 Dec 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • BARTLETT, M. S. 1954. A note on multiplying factors for various chi-squared approximations. Joural of the Royal Statistical Society, Series B, 296-298.

  • Bleichrodt H, Johannesson M. An experimental test of a theoretical foundation for rating-scale valuations. Med Decis Making. 1997 Apr-Jun;17(2):208-16. doi: 10.1177/0272989X9701700212.

    PubMed 9107617
  • de Boer AG, van Lanschot JJ, Stalmeier PF, van Sandick JW, Hulscher JB, de Haes JC, Sprangers MA. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res. 2004 Mar;13(2):311-20. doi: 10.1023/B:QURE.0000018499.64574.1f.

    PubMed 15085903
  • Caballero FF, Miret M, Power M, Chatterji S, Tobiasz-Adamczyk B, Koskinen S, Leonardi M, Olaya B, Haro JM, Ayuso-Mateos JL. Validation of an instrument to evaluate quality of life in the aging population: WHOQOL-AGE. Health Qual Life Outcomes. 2013 Oct 23;11:177. doi: 10.1186/1477-7525-11-177.

    PubMed 24152691
  • Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983 May;16(1):87-101. doi: 10.1016/0304-3959(83)90088-X.

    PubMed 6602967
  • COSTELLO, A. & OSBORNE, J. 2005. Best Practices in Exploratory Factor Analysis: Four Recommendations for Getting the Most From Your Analysis. Practical Assessment and Research Evaluation, 10, 1-9.

  • CRESWELL, J. W. & CLARK, V. L. P. 2011. Designing and conducting mixed methods research, SAGE.

  • Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985 Feb;49(1):71-5. doi: 10.1207/s15327752jpa4901_13.

    PubMed 16367493
  • DZIUBAN, C. D. & SHIRKEY, E. C. 1974. When is a correlation matrix appropriate for factor analysis? Some decision rules. Psychological Bulletin, 81, 358-361

  • EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208. doi: 10.1016/0168-8510(90)90421-9.

    PubMed 10109801
  • FABRIGAR, L., WEGENER, D., MACCALLUM, R. & STRAHAN, E. 1999. Evaluating the use of exploratory factor analysis in psychological research. Psychological Methods, 4, 272-299

  • KAISER, H. F. 1970. A second generation little jiffy. Psychometrika, 35, 401-415.

  • KAISER HF, CAFFREY J. ALPHA FACTOR ANALYSIS. Psychometrika. 1965 Mar;30:1-14. doi: 10.1007/BF02289743. No abstract available.

    PubMed 14293189
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977 Mar;33(1):159-74.

    PubMed 843571
  • Leung KF, Liu FB, Zhao L, Fang JQ, Chan K, Lin LZ. Development and validation of the Chinese Quality of Life Instrument. Health Qual Life Outcomes. 2005 Apr 16;3:26. doi: 10.1186/1477-7525-3-26.

    PubMed 15833138

Questions about this trial

What is this clinical trial studying?

An observational study of Quality of Life, run by University of Nottingham at 14 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 14 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Deborah Oliveira (07463491670, deborah.oliveira@nottingham.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Health related quality of life (HRQoL) (time frame: 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02463734, which also lists 29 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in